Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.98

+1.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Metcalf who wrote (1905)	10/27/2000 3:04:53 AM
From: scott_jiminez	Read Replies (1) of 52153

Jeopardy answer: North American Resorts. Correct question: What was the name of the company now called 'Immulabs' until about a month ago? biz.yahoo.com 'The new name highlights internal moves to..... ' From 'resorts' to biotech in one 'internal move'. Generally, the psycho-physiologic 'internal'symptoms associated with such 'moves' include elevated peristalsis and excessive flatulence. Declaring a 4:1 split on a $7 stock indicates an heretofore unreported pathological cognitive component - perhaps associated with a tome-like rap sheet - as part of this internal movement. This story is indeed unique for biotech. The fact that Traub went for BT (and not dot coms, etc.) suggests there's lot's of easy financing out there...that BT is where the money's at. Could be an early yellow flag. Then again, BT may the only sector to survive this massacre relatively unscathed <VBG>.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next